NCT03453489 2025-04-10AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine NeoplasmBarbara Ann Karmanos Cancer InstitutePhase 2 Completed4 enrolled 7 charts
NCT04543955 2023-06-27Telotristat With Lutathera in Neuroendocrine TumorsUniversity of KentuckyPhase 2 Terminated1 enrolled 4 charts